Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erteberel for Negative Symptoms and Cognitive Impairment in Schizophrenia
NCT01874756Phase 2Terminated
- Sponsor
- Indiana University
- Start
- Jun 2013
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erteberel in schizophrenia, sponsored by Indiana University. Started Jun 2013; status: terminated.
02
Drugs
erteberel
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01874756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01874756.